CDC50A and mantle cell lymphoma: We targeted tmem30A with CRISPR-Cas9 in the mantle cell lymphoma (MCL) cell line JeKo-1 to develop genetically modified knockout cell lines that constitutively externalize cell surface PS (TMEM30A KO).